Anti-ceramide single-chain variable fragment mitigates radiation GI syndrome mortality independent of DNA repair

Abstract excerpt

After 9/11, threat of nuclear attack on American urban centers prompted government agencies to develop medical radiation countermeasures to mitigate hematopoietic acute radiation syndrome (H-ARS) and higher-dose gastrointestinal acute radiation syndrome (GI-ARS) lethality. While repurposing leukemia drugs that enhance bone marrow repopulation successfully treats H-ARS in preclinical models, no mitigator...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Effects of Radiation Exposure
• Share to Hematopoietic Stem Cell Transplantation
• Share to PARP inhibition in cancer therapy